Vital Signs: Estimated Effects of a Coordinated Approach for Action to Reduce Antibiotic-Resistant Infections in Health Care Facilities - United States
- PMID: 26247436
- PMCID: PMC4654955
Vital Signs: Estimated Effects of a Coordinated Approach for Action to Reduce Antibiotic-Resistant Infections in Health Care Facilities - United States
Abstract
Background: Treatments for health care-associated infections (HAIs) caused by antibiotic-resistant bacteria and Clostridium difficile are limited, and some patients have developed untreatable infections. Evidence-supported interventions are available, but coordinated approaches to interrupt the spread of HAIs could have a greater impact on reversing the increasing incidence of these infections than independent facility-based program efforts.
Methods: Data from CDC's National Healthcare Safety Network and Emerging Infections Program were analyzed to project the number of health care-associated infections from antibiotic-resistant bacteria or C. difficile both with and without a large scale national intervention that would include interrupting transmission and improved antibiotic stewardship. As an example, the impact of reducing transmission of one antibiotic-resistant infection (carbapenem-resistant Enterobacteriaceae [CRE]) on cumulative prevalence and number of HAI transmission events within interconnected groups of health care facilities was modeled using two distinct approaches, a large scale and a smaller scale health care network.
Results: Immediate nationwide infection control and antibiotic stewardship interventions, over 5 years, could avert an estimated 619,000 HAIs resulting from CRE, multidrug-resistant Pseudomonas aeruginosa, invasive methicillin-resistant Staphylococcus aureus (MRSA), or C. difficile. Compared with independent efforts, a coordinated response to prevent CRE spread across a group of inter-connected health care facilities resulted in a cumulative 74% reduction in acquisitions over 5 years in a 10-facility network model, and 55% reduction over 15 years in a 102-facility network model.
Conclusions: With effective action now, more than half a million antibiotic-resistant health care-associated infections could be prevented over 5 years. Models representing both large and small groups of interconnected health care facilities illustrate that a coordinated approach to interrupting transmission is more effective than historical independent facilitybased efforts.
Implications for public health: Public health-led coordinated prevention approaches have the potential to more completely address the emergence and dissemination of these antibiotic-resistant organisms and C. difficile than independent facility-based efforts.
Figures
Similar articles
-
Vital Signs: Preventing Antibiotic-Resistant Infections in Hospitals - United States, 2014.MMWR Morb Mortal Wkly Rep. 2016 Mar 11;65(9):235-41. doi: 10.15585/mmwr.mm6509e1. MMWR Morb Mortal Wkly Rep. 2016. PMID: 26963489
-
Effect of antibiotic stewardship on the incidence of infection and colonisation with antibiotic-resistant bacteria and Clostridium difficile infection: a systematic review and meta-analysis.Lancet Infect Dis. 2017 Sep;17(9):990-1001. doi: 10.1016/S1473-3099(17)30325-0. Epub 2017 Jun 16. Lancet Infect Dis. 2017. PMID: 28629876 Review.
-
The Potential Trajectory of Carbapenem-Resistant Enterobacteriaceae, an Emerging Threat to Health-Care Facilities, and the Impact of the Centers for Disease Control and Prevention Toolkit.Am J Epidemiol. 2016 Mar 1;183(5):471-9. doi: 10.1093/aje/kwv299. Epub 2016 Feb 8. Am J Epidemiol. 2016. PMID: 26861238 Free PMC article.
-
[Healthcare associated infections (HAI), antibiotic use and prevalence of multidrug-resistant bacteria (MDRO) in residents of long-term care facilities: the Frankfurt HALT plus MDRO project 2012].Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2014 Apr;57(4):414-22. doi: 10.1007/s00103-013-1927-7. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2014. PMID: 24658671 German.
-
The continuing crisis in antibiotic resistance.Int J Antimicrob Agents. 2010 Nov;36 Suppl 3:S3-7. doi: 10.1016/S0924-8579(10)70003-0. Int J Antimicrob Agents. 2010. PMID: 21129629 Review.
Cited by
-
An Overview of the Recent Advances in Antimicrobial Resistance.Microorganisms. 2024 Sep 21;12(9):1920. doi: 10.3390/microorganisms12091920. Microorganisms. 2024. PMID: 39338594 Free PMC article. Review.
-
Healthcare as a driver, reservoir and amplifier of antimicrobial resistance: opportunities for interventions.Nat Rev Microbiol. 2024 Oct;22(10):636-649. doi: 10.1038/s41579-024-01076-4. Epub 2024 Jul 24. Nat Rev Microbiol. 2024. PMID: 39048837 Review.
-
Development and implementation of a nationwide multidrug-resistant organism tracking and alert system for Veterans Affairs medical centers.Infect Control Hosp Epidemiol. 2024 May 24;45(9):1-6. doi: 10.1017/ice.2024.79. Online ahead of print. Infect Control Hosp Epidemiol. 2024. PMID: 38785174 Free PMC article.
-
Regional impact of multidrug-resistant organism prevention bundles implemented by facility type: A modeling study.Infect Control Hosp Epidemiol. 2024 Jul;45(7):856-863. doi: 10.1017/ice.2023.278. Epub 2024 Feb 28. Infect Control Hosp Epidemiol. 2024. PMID: 38415308 Free PMC article.
-
System identifiability in a time-evolving agent-based model.PLoS One. 2024 Jan 25;19(1):e0290821. doi: 10.1371/journal.pone.0290821. eCollection 2024. PLoS One. 2024. PMID: 38271401 Free PMC article.
References
-
- CDC. Antibiotic resistance threats in the United States, 2013. Atlanta, GA: US Department of Health and Human Services, CDC; 2013. Available at http://www.cdc.gov/drugresistance/threat-report-2013.
-
- Burton DC, Edwards JR, Horan TC, Jernigan JA, Fridkin SK. Methicillin-resistant Staphylococcus aureus central line-associated bloodstream infections in US intensive care units, 1997–2007. JAMA. 2009;301:727–36. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
